Diagnosing acute HIV infection

References

• Quinn TC, Wawer MJ, Sewankambo N et al. Viral load and heterosexual transmission of human immunodeficiency virus Type 1. Rakai project study group. N. Engl. J. Med.342, 921–929 (2000).
   PubMed Web of Science ®Google Scholar
• Daar ES, Moudgil T, Meyer RD, Ho DD. Transient high levels of viremia in patients with primary human immunodeficiency virus type 1 infection. N. Engl. J. Med.324, 961–964 (1991).
   PubMed Web of Science ®Google Scholar
• Pilcher CD, Joaki G, Hoffman IF et al. Amplified transmission of HIV-1: comparison of HIV-1 concentrations in semen and blood during acute and chronic infection. AIDS21, 1723–1730 (2007).
   PubMed Web of Science ®Google Scholar
• Morrison CS, Demers K, Kwok C et al. Plasma and cervical viral loads among Ugandan and Zimbabwean women during acute and early HIV-1 infection. AIDS24, 573–582 (2010).
   PubMedGoogle Scholar
• Yerly S, Vora S, Rizzardi P et al. Acute HIV infection: impact on the spread of HIV and transmission of drug resistance. AIDS15, 2287–2292 (2001).
   PubMed Web of Science ®Google Scholar
• Yerly S, Junier T, Gayet-Ageron A et al. The impact of transmission clusters on primary drug resistance in newly diagnosed HIV-1 infection. AIDS23, 1415–1423 (2009).
   PubMed Web of Science ®Google Scholar
• Brenner BG, Roger M, Routy JP et al. Quebec primary HIV infection study group. High rates of forward transmission events after acute/early HIV-1 infection. J. Infect. Dis.195, 951–959 (2007).
   PubMed Web of Science ®Google Scholar
• Lewis F, Hughes GJ, Rambaut A, Pozniak A, Leigh Brown AJ. Episodic sexual transmission of HIV revealed by molecular phylodynamics. PLoS Med5, e50 (2008).
   Web of Science ®Google Scholar
• Cohen MS, Shaw GM, McMichael AJ, Haynes BF. Acute HIV-1 infection. N. Engl. J. Med.364, 1943–1954 (2011).
   PubMed Web of Science ®Google Scholar
• Miller WC, Rosenberg NE, Rutstein SE, Powers KA. Role of acute and early HIV infection in the sexual transmission of HIV. Curr. Opin. HIV AIDS5, 277–282 (2010).
   PubMed Web of Science ®Google Scholar
• Wawer MJ, Gray RH, Sewankambo NK et al. Rates of HIV-1 transmission per coital act, by stage of HIV-1 infection, in Rakai, Uganda. J. Infect. Dis.191, 1403–1409 (2005).
   PubMed Web of Science ®Google Scholar
• Hollingsworth TD, Anderson RM, Fraser C. HIV-1 transmission, by stage of infection. J. Infect. Dis.198, 687–693 (2008).
   PubMed Web of Science ®Google Scholar
• Powers KA, Ghani AC, Miller WC et al. The role of acute and early HIV infection in the spread of HIV and implications for transmission prevention strategies in Lilongwe, Malawi: a modelling study. Lancet378, 256–268 (2011).
   PubMed Web of Science ®Google Scholar
• Cohen MS, Chen YQ, McCauley M et al. Prevention of HIV-1 infection with early antiretroviral therapy. N. Engl. J. Med.365, 493–505 (2011).
   PubMed Web of Science ®Google Scholar
• Li Q, Skinner PJ, Ha SJ et al. Visualizing antigen-specific and infected cells in situ predicts outcomes in early viral infection. Science323, 1726–1729 (2009).
   PubMed Web of Science ®Google Scholar
• Miller CJ, Li Q, Abel K et al. Propagation and dissemination of infection after vaginal transmission of simian immunodeficiency virus. J. Virol.79, 9217–9227 (2005).
   PubMed Web of Science ®Google Scholar
• Brenchley JM, Schacker TW, Ruff LE et al. CD4+ T cell depletion during all stages of HIV disease occurs predominantly in the gastrointestinal tract. J. Exp. Med.200, 749–759 (2004).
   PubMed Web of Science ®Google Scholar
• Veazey RS, DeMaria M, Chalifoux LV et al. Gastrointestinal tract as a major site of CD4+ T cell depletion and viral replication in SIV infection. Science280, 427–431 (1998).
   PubMed Web of Science ®Google Scholar
• Mattapallil JJ, Douek DC, Hill B, Nishimura Y, Martin M, Roederer M. Massive infection and loss of memory CD4+ T cells in multiple tissues during acute SIV infection. Nature434, 1093–1097 (2005).
   PubMed Web of Science ®Google Scholar
• Schacker T, Little S, Connick E et al. Productive infection of T cells in lymphoid tissues during primary and early human immunodeficiency virus infection. J. Infect. Dis.183, 555–562 (2001).
   PubMed Web of Science ®Google Scholar
• Fiebig EW, Wright DJ, Rawal BD et al. Dynamics of HIV viremia and antibody seroconversion in plasma donors: implications for diagnosis and staging of primary HIV infection. AIDS17, 1871–1879 (2003).
   PubMed Web of Science ®Google Scholar
• Tindall B, Barker S, Donovan B et al. Characterization of the acute clinical illness associated with human immunodeficiency virus infection. Arch. Intern. Med.148, 945–949 (1988).
   PubMed Web of Science ®Google Scholar
• Ward JW, Bush TJ, Perkins HA et al. The natural history of transfusion-associated infection with human immunodeficiency virus. Factors influencing the rate of progression to disease. N. Engl. J. Med.321, 947–952 (1989).
   PubMedGoogle Scholar
• Schacker T, Collier AC, Hughes J, Shea T, Corey L. Clinical and epidemiologic features of primary HIV infection. Ann. Intern. Med.125, 257–264 (1996).
   PubMed Web of Science ®Google Scholar
• Lavreys L, Thompson ML, Martin HL Jr et al. Primary human immunodeficiency virus type 1 infection: clinical manifestations among women in Mombasa, Kenya. Clin. Infect. Dis.30, 486–490 (2000).
   PubMed Web of Science ®Google Scholar
• Hecht FM, Busch MP, Rawal B et al. Use of laboratory tests and clinical symptoms for identification of primary HIV infection. AIDS16, 1119–1129 (2002).
   PubMed Web of Science ®Google Scholar
• Daar ES, Little S, Pitt J et al. Diagnosis of primary HIV-1 infection. Los Angeles county primary HIV infection recruitment network. Ann. Intern. Med.134, 25–29 (2001).
   PubMed Web of Science ®Google Scholar
• Vanhems P, Hughes J, Collier AC et al. Comparison of clinical features, CD4 and CD8 responses among patients with acute HIV-1 infection from Geneva, Seattle and Sydney. AIDS14, 375–381 (2000).
   PubMedGoogle Scholar
• Kinloch-De Loës S, Hirschel B, Hoen B et al. A controlled trial of zidovudine in primary human immunodeficiency virus infection. N. Engl. J. Med.333, 408–413 (1995).
   PubMed Web of Science ®Google Scholar
• Chu C, Selwyn PA. Diagnosis and initial management of acute HIV infection. Am. Fam. Physician81, 1239–1244 (2010).
   PubMed Web of Science ®Google Scholar
• Miller WC, Leone PA, McCoy S, Nguyen TQ, Williams DE, Pilcher CD. Targeted testing for acute HIV infection in North Carolina. AIDS23, 835–843 (2009).
   PubMedGoogle Scholar
• Powers KA, Miller WC, Pilcher CD et al. Malawi UNC project acute HIV study team. Improved detection of acute HIV-1 infection in sub-Saharan Africa: development of a risk score algorithm. AIDS21, 2237–2242 (2007).
   PubMed Web of Science ®Google Scholar
• Tomaras GD, Yates NL, Liu P et al. Initial B-cell responses to transmitted human immunodeficiency virus type 1: virion-binding immunoglobulin M (IgM) and IgG antibodies followed by plasma anti-gp41 antibodies with ineffective control of initial viremia. J. Virol.82, 12449–12463 (2008).
   PubMed Web of Science ®Google Scholar
• Fellay J, Shianna KV, Telenti A, Goldstein DB. Host genetics and HIV-1: the final phase? PLoS Pathog.6, e1001033 (2010).
   PubMed Web of Science ®Google Scholar
• McMichael AJ, Borrow P, Tomaras GD, Goonetilleke N, Haynes BF. The immune response during acute HIV-1 infection: clues for vaccine development. Nat. Rev. Immunol.10, 11–23 (2010).
   PubMed Web of Science ®Google Scholar
• Petersen LR, Satten GA, Dodd R et al. Duration of time from onset of human immunodeficiency virus type 1 infectiousness to development of detectable antibody. Transfusion34, 283–289 (1994).
   PubMed Web of Science ®Google Scholar
• Devare SG. Early diagnosis of HIV infection. J. Med. Virol.79, S11–S15 (2007).
   Web of Science ®Google Scholar
• Gallarda JL, Henrard DR, Liu D et al. Early detection of antibody to human immunodeficiency virus Type 1 by using an antigen conjugate immunoassay correlates with the presence of immunoglobulin M antibody. J. Clin. Microbiol.30, 2379–2384 (1992).
   PubMed Web of Science ®Google Scholar
• Thorstensson R, Andersson S, Lindbäck S et al. Evaluation of 14 commercial HIV-1/HIV-2 antibody assays using serum panels of different geographical origin and clinical stage including a unique seroconversion panel. J. Virol. Methods70, 139–151 (1998).
   PubMed Web of Science ®Google Scholar
• Weber B, Orazi B, Raineri A et al. Multicenter evaluation of a new 4th generation HIV screening assay Elecsys HIV combi. Clin. Lab52, 463–473 (2006).
   PubMed Web of Science ®Google Scholar
• Weber B, Fall EH, Berger A, Doerr HW. Reduction of diagnostic window by new fourth-generation human immunodeficiency virus screening assays. J. Clin. Microbiol.36, 2235–2239 (1998).
   PubMed Web of Science ®Google Scholar
• van Binsbergen J, Keur W, Siebelink A et al. Strongly enhanced sensitivity of a direct anti-HIV-1/-2 assay in seroconversion by incorporation of HIV p24 Ag detection: a new generation Vironostika HIV Uni-Form II. J. Virol. Methods76, 59–71 (1998).
   PubMed Web of Science ®Google Scholar
• Ly TD, Laperche S, Brennan C et al. Evaluation of the sensitivity and specificity of six HIV combined p24 antigen and antibody assays. J. Virol. Methods122, 185–194 (2004).
   PubMed Web of Science ®Google Scholar
• Eshleman SH, Khaki L, Laeyendecker O et al. Detection of individuals with acute HIV-1 infection using the ARCHITECT HIV Ag/Ab Combo assay. J. Acquir. Immu. Defic. Syndr.52, 121–124 (2009).
   PubMed Web of Science ®Google Scholar
• Stekler JD, Swenson PD, Coombs RW et al. HIV testing in a high-incidence population: is antibody testing alone good enough? Clin. Infect. Dis.49, 444–453 (2009).
   PubMed Web of Science ®Google Scholar
• Patel P, Mackellar D, Simmons P et al. Detecting acute human immunodeficiency virus infection using 3 different screening immunoassays and nucleic acid amplification testing for human immunodeficiency virus RNA, 2006–2008. Arch. Intern. Med.170, 66–74 (2010).
   PubMed Web of Science ®Google Scholar
• Malm K, von Sydow M, Andersson S. Performance of three automated fourth-generation combined HIV antigen/antibody assays in large-scale screening of blood donors and clinical samples. Transfus. Med.19, 78–88 (2009).
   PubMedGoogle Scholar
• Sickinger E, Stieler M, Kaufman B et al. Multicenter evaluation of a new, automated enzyme-linked immunoassay for detection of human immunodeficiency virus-specific antibodies and antigen. J. Clin. Microbiol.42, 21–29 (2004).
   PubMedGoogle Scholar
• Pandori MW, Hackett J Jr, Louie B et al. Assessment of the ability of a fourth-generation immunoassay for human immunodeficiency virus (HIV) antibody and p24 antigen to detect both acute and recent HIV infections in a high-risk setting. J. Clin. Microbiol.47, 2639–2642 (2009).
   PubMed Web of Science ®Google Scholar
• Bischof JJ, Kuruc JD, Embry JA et al. Prospective Study of the ARCHITECTHIV Ag/Ab Combo 4th generation assay to detect HIV infection in STI clinics. AIDS25(15), 1927–1929 (2011).
   PubMedGoogle Scholar
• Gay C, Dibben O, Anderson JA et al. Cross-sectional detection of acute HIV infection: timing of transmission, inflammation and antiretroviral therapy. PLoS One6, e19617 (2011).
   Google Scholar
• Pilcher CD, Fiscus SA, Nguyen TQ et al. Detection of acute infections during HIV testing in North Carolina. N. Engl. J. Med.352, 1873–1883 (2005).
   PubMed Web of Science ®Google Scholar
• Patel P, Klausner JD, Bacon OM et al. Detection of acute HIV infections in high-risk patients in California. J. Acquir. Immu. Defic. Syndr.42, 75–79 (2006).
   PubMed Web of Science ®Google Scholar
• Priddy FH, Pilcher CD, Moore RH et al. Detection of acute HIV infections in an urban HIV counseling and testing population in the United States. J. Acquir. Immu. Defic. Syndr.44, 196–202 (2007).
   PubMedGoogle Scholar
• Fiscus SA, Pilcher CD, Miller WC et al. Rapid, real-time detection of acute HIV infection in patients in Africa. J. Infect. Dis.195, 416–424 (2007).
   PubMedGoogle Scholar
• Stekler J, Swenson PD, Wood RW, Handsfield HH, Golden MR. Targeted screening for primary HIV infection through pooled HIV-RNA testing in men who have sex with men. AIDS19, 1323–1325 (2005).
   PubMed Web of Science ®Google Scholar
• Gous N, Scott L, Perovic O, Venter F, Stevens W. Should South Africa be performing nucleic acid testing on HIV enzyme-linked immunosorbent assay-negative samples? J. Clin. Microbiol.48, 3407–3409 (2010).
   PubMedGoogle Scholar
• Patterson KB, Leone PA, Fiscus SA et al. Frequent detection of acute HIV infection in pregnant women. AIDS21, 2303–2308 (2007).
   PubMed Web of Science ®Google Scholar
• Morris SR, Little SJ, Cunningham T, Garfein RS, Richman DD, Smith DM. Evaluation of an HIV nucleic acid testing program with automated Internet and voicemail systems to deliver results. Ann. Intern. Med.152, 778–785 (2010).
   PubMedGoogle Scholar
• Truong HM, Grant RM, McFarland W et al. Routine surveillance for the detection of acute and recent HIV infections and transmission of antiretroviral resistance. AIDS20, 2193–2197 (2006).
   PubMed Web of Science ®Google Scholar
• Temkin E, Marsiglia VC, Hague C, Erbelding E. Screening for acute human immunodeficiency virus infection in baltimore public testing sites. Sex Transm. Dis.38, 374–377 (2011).
   PubMedGoogle Scholar
• Greenwald JL, Burstein GR, Pincus J, Branson B. A rapid review of rapid HIV antibody tests. Curr. Infect. Dis. Rep.8, 125–131 (2006).
   PubMedGoogle Scholar
• Hutchinson AB, Branson BM, Kim A, Farnham PG. A meta-analysis of the effectiveness of alternative HIV counseling and testing methods to increase knowledge of HIV status. AIDS20, 1597–1604 (2006).
   PubMed Web of Science ®Google Scholar
• Learmonth KM, McPhee DA, Jardine DK et al. Assessing proficiency of interpretation of rapid human immunodeficiency virus assays in nonlaboratory settings: ensuring quality of testing. J. Clin. Microbiol.46, 1692–1697 (2008).
   PubMed Web of Science ®Google Scholar
• Chiu YH, Ong J, Walker S et al. Photographed rapid HIV test results pilot novel quality assessment and training schemes. PLoS One6, e18294 (2011).
   Google Scholar
• Pavie J, Rachline A, Loze B et al. Sensitivity of five rapid HIV tests on oral fluid or finger-stick whole blood: a real-time comparison in a healthcare setting. PLoS One5, e11581 (2010).
   Google Scholar
• Laforgerie E, Boucher B, Ly TD et al. Sensitivity of 8 CE (European Community)-approved rapid disposable tests for anti-HIV antibody detection during and after seroconversion. J. Virol. Methods165, 105–107 (2010).
   PubMed Web of Science ®Google Scholar
• Delaney KP, Branson BM, Uniyal A et al. Evaluation of the performance characteristics of 6 rapid HIV antibody tests. Clin. Infect. Dis.52, 257–263 (2011).
   PubMed Web of Science ®Google Scholar
• Black V, von Mollendorf CE, Moyes JA, Scott LE, Puren A, Stevens WS. Poor sensitivity of field rapid HIV testing: implications for mother-to-child transmission programme. BJOG116, 1805–1808 (2009).
   PubMedGoogle Scholar
• Klarkowski DB, Wazome JM, Lokuge KM, Shanks L, Mills CF, O’Brien DP. The evaluation of a rapid in situ HIV confirmation test in a programme with a high failure rate of the WHO HIV two-test diagnostic algorithm. PLoS One4, e4351 (2009).
   PubMed Web of Science ®Google Scholar
• Aghokeng AF, Mpoudi-Ngole E, Dimodi H et al. Inaccurate diagnosis of HIV-1 group M and O is a key challenge for ongoing universal access to antiretroviral treatment and HIV prevention in Cameroon. PLoS One4, e7702 (2009).
   PubMedGoogle Scholar
• Walensky RP, Arbelaez C, Reichmann WM et al. Revising expectations from rapid HIV tests in the emergency department. Ann. Intern. Med.149, 153–160 (2008).
   PubMedGoogle Scholar
• Gray RH, Makumbi F, Serwadda D et al. Limitations of rapid HIV-1 tests during screening for trials in Uganda: diagnostic test accuracy study. BMJ335, 188–191 (2007).
   PubMed Web of Science ®Google Scholar
• Beelaert G, Fransen K. Evaluation of a rapid and simple fourth-generation HIV screening assay for qualitative detection of HIV p24 antigen and/or antibodies to HIV-1 and HIV-2. J. Virol. Methods168, 218–222 (2010).
   PubMedGoogle Scholar
• Poljak M, Smit E, Ross J. 2008 European guideline on HIV testing. Int. J. STD AIDS.20, 77–83 (2009).
   PubMed Web of Science ®Google Scholar
• Korn K, Weissbrich B, Henke-Gendo C et al. Single-point mutations causing more than 100-fold underestimation of human immunodeficiency virus Type 1 (HIV-1) load with the Cobas TaqMan HIV-1 real-time PCR assay. J. Clin. Microbiol.47, 1238–1240 (2009).
   PubMed Web of Science ®Google Scholar
• Colson P, Solas C, Moreau J, Motte A, Henry M, Tamalet C. Impaired quantification of plasma HIV-1 RNA with a commercialized real-time PCR assay in a couple of HIV-1-infected individuals. J. Clin. Virol.39, 226–229 (2007).
   PubMedGoogle Scholar
• Damond F, Roquebert B, Bénard A et al. Human immunodeficiency virus type 1 (HIV-1) plasma load discrepancies between the Roche COBAS AMPLICOR HIV-1 MONITOR version 1.5 and the Roche COBAS AmpliPrep/COBAS TaqMan HIV-1 assays. J. Clin. Microbiol.45, 3436–3438 (2007).
   PubMed Web of Science ®Google Scholar
• Holguín M, López M, Molinero V. Soriano, Performance of three commercial viral load assays, versant human immunodeficiency virus Type 1 (HIV-1) RNA bDNA v3.0, Cobas AmpliPrep/Cobas TaqMan HIV-1, and NucliSens HIV-1 EasyQ v1.2, testing HIV-1 non-B subtypes and recombinant variants. J. Clin. Microbiol.46, 2918–2923 (2008).
   PubMed Web of Science ®Google Scholar
• Ross L, Lim ML, Liao Q et al. Prevalence of antiretroviral drug resistance and resistance-associated mutations in antiretroviral therapy-naive HIV-infected individuals from 40 United States cities. HIV Clin. Trials8, 1–8 (2007).
   PubMed Web of Science ®Google Scholar
• Huang HY, Daar ES, Sax PE et al. The prevalence of transmitted antiretroviral drug resistance in treatment-naive patients and factors influencing first-line treatment regimen selection. HIV Med.9, 285–293 (2008).
   PubMed Web of Science ®Google Scholar
• Wheeler WH, Ziebell RA, Zabina H et al. Prevalence of transmitted drug resistance associated mutations and HIV-1 subtypes in new HIV-1 diagnoses, U.S. – 2006. AIDS24, 1203–1212 (2010).
   PubMed Web of Science ®Google Scholar
• Vercauteren J, Wensing AM, van de Vijver DA et al. Transmission of drug-resistant HIV-1 is stabilizing in Europe. J. Infect. Dis.200, 1503–1508 (2009).
   PubMed Web of Science ®Google Scholar
• Rich JD, Merriman NA, Mylonakis E et al. Misdiagnosis of HIV infection by HIV-1 plasma viral load testing: a case series. Ann. Intern. Med.130, 37–39 (1999).
   PubMedGoogle Scholar
• van Zyl GU, Korsman SN, Maree L, Preiser W. NucliSens EasyQ HIV-1 V1.2 system: detection of human plasma-derived background signal. J. Virol. Methods165, 318–319 (2010).
   PubMedGoogle Scholar
• Kakaiya R, Gordon S, Zimmerman A, Verlinsky R, Ahmed S, Phillips M. False-positive nucleic acid test results for human immunodeficiency virus RNA and hepatitis C virus RNA: an underappreciated problem. Transfusion51, 225–226 (2011).
   PubMedGoogle Scholar
• Coco A, Kleinhans E. Prevalence of primary HIV infection in symptomatic ambulatory patients. Ann. Fam. Med3, 400–404 (2005).
   PubMedGoogle Scholar
• Pincus JM, Crosby SS, Losina E et al. Acute human immunodeficiency virus infection in patients presenting to an urban urgent care center. Clin. Infect. Dis37, 1699–1704 (2003).
   PubMedGoogle Scholar
• Rosenberg ES, Caliendo AM, Walker BD. Acute HIV infection among patients tested for mononucleosis. N. Engl. J. Med.340, 969 (1999).
   PubMedGoogle Scholar
• Bebell LM, Pilcher CD, Dorsey G et al. Acute HIV-1 infection is highly prevalent in Ugandan adults with suspected malaria. AIDS24, 1945–1952 (2010).
   PubMedGoogle Scholar
• Hutchinson AB, Patel P, Sansom SL et al. Cost-effectiveness of pooled nucleic acid amplification testing for acute HIV infection after third-generation HIV antibody screening and rapid testing in the United States: a comparison of three public health settings. PLoS Med.7, e1000342 (2010).
   PubMed Web of Science ®Google Scholar
• Juusola JL, Brandeau ML, Long EF, Owens DK, Bendavid E. The cost–effectiveness of symptom-based testing and routine screening for acute HIV infection in men who have sex with men in the United States. AIDS25, 1779–1787 (2011).
   PubMed Web of Science ®Google Scholar
• Pilcher CD, Christopoulos KA, Golden M. Public health rationale for rapid nucleic acid or p24 antigen tests for HIV. J. Infect. Dis.201(Suppl. 1), S7–S15 (2010).
   PubMed Web of Science ®Google Scholar
• Tang W, Chow WH, Li Y, Kong H, Tang YW, Lemieux B. Nucleic acid assay system for tier II laboratories and moderately complex clinics to detect HIV in low-resource settings. J. Infect. Dis.201(Suppl. 1), S46–S51 (2010).
   PubMed Web of Science ®Google Scholar
• Tang S, Hewlett I. Nanoparticle-based immunoassays for sensitive and early detection of HIV-1 capsid (p24) antigen. J. Infect. Dis.201(Suppl. 1), S59–S64 (2010).
   PubMed Web of Science ®Google Scholar
• Lee HH, Dineva MA, Chua YL, Ritchie AV, Ushiro-Lumb I, Wisniewski CA. Simple amplification-based assay: a nucleic acid-based point-of care platform for HIV-1 testing. J. Infect. Dis.201(Suppl. 1), S65–S72 (2010).
   PubMed Web of Science ®Google Scholar
• Wang S, Xu F, Demirci U. Advances in developing HIV-1 viral load assays for resource-limited settings. Biotechnol. Adv.28, 770–781 (2010).
   PubMed Web of Science ®Google Scholar